INFU Stock Overview Through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
InfuSystem Holdings, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for InfuSystem Holdings Historical stock prices Current Share Price US$8.31 52 Week High US$10.89 52 Week Low US$5.74 Beta 1.53 1 Month Change -7.87% 3 Month Change 28.64% 1 Year Change -22.34% 3 Year Change -50.86% 5 Year Change 1.09% Change since IPO 55.04%
Recent News & Updates
Less than half of directors are independent Dec 12
InfuSystem Holdings, Inc. Appoints Ronald Hundzinski to the Board of Directors Nov 19
New minor risk - Share price stability Nov 12
Third quarter 2024 earnings: EPS and revenues exceed analyst expectations Nov 09
Infusystem Holdings, Inc. Provides Revenue Guidance for the Full Year 2024 Nov 08
Insider exercised options and sold US$54k worth of stock Nov 06 See more updates
Less than half of directors are independent Dec 12
InfuSystem Holdings, Inc. Appoints Ronald Hundzinski to the Board of Directors Nov 19
New minor risk - Share price stability Nov 12
Third quarter 2024 earnings: EPS and revenues exceed analyst expectations Nov 09
Infusystem Holdings, Inc. Provides Revenue Guidance for the Full Year 2024 Nov 08
Insider exercised options and sold US$54k worth of stock Nov 06
InfuSystem Holdings, Inc. to Report Q3, 2024 Results on Nov 07, 2024 Oct 31
Price target decreased by 11% to US$14.17 Aug 13
Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Aug 09
Infusystem Holdings, Inc. Reaffirms Earnings Guidance for the Full Year 2024 Aug 08
InfuSystem Holdings, Inc. to Report Q2, 2024 Results on Aug 08, 2024 Aug 03
CEO & Director exercised options and sold US$142k worth of stock Jun 30
Less than half of directors are independent Jun 14 InfuSystem Holdings, Inc. (NYSEAM:INFU) announces an Equity Buyback for $20 million worth of its shares. May 21
InfuSystem Holdings, Inc. Approves Directorate Elections May 18
InfuSystem Holdings, Inc. Reaffirms Earnings Guidance for the Full Year 2024 May 10
InfuSystem Holdings, Inc. to Report Q1, 2024 Results on May 09, 2024 May 03 InfuSystem Holdings, Inc., Annual General Meeting, May 16, 2024 InfuSystem Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 10-K Apr 03
InfuSystem Holdings, Inc. announced delayed annual 10-K filing
Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat Mar 15
InfuSystem Holdings, Inc. Announces Resignation of R. Rimmy Malhotra as Member of the Board Mar 10
InfuSystem Holdings, Inc. to Report Q4, 2023 Results on Mar 14, 2024 Mar 09
New minor risk - Shareholder dilution Nov 08 InfuSystem Holdings, Inc. Provides Revenue Guidance for the Fourth Quarter of 2023
InfuSystem Holdings, Inc. to Report Q3, 2023 Results on Nov 07, 2023 Nov 01
CEO & Director exercised options and sold US$870k worth of stock Aug 23
Consensus EPS estimates fall by 25%, revenue upgraded Aug 10
InfuSystem Holdings, Inc. Revises Earnings Guidance for the Year 2023 Aug 04
Second quarter 2023 earnings: EPS and revenues exceed analyst expectations Aug 04
Second quarter 2023 earnings: EPS and revenues exceed analyst expectations Aug 04
Now 20% undervalued Aug 03
InfuSystem Holdings, Inc. to Report Q2, 2023 Results on Aug 03, 2023 Jul 29
President exercised options and sold US$79k worth of stock Jul 05
Independent Director notifies of intention to sell stock Jun 19
Now 20% undervalued after recent price drop Jun 06
Now 21% undervalued after recent price drop May 18
Consensus EPS estimates fall by 15% May 11
First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind May 06
InfuSystem Holdings, Inc. Reaffirms Earnings Guidance for the Full Year 2023 May 05
Executive VP & CFO exercised options and sold US$92k worth of stock Mar 23
Full year 2022 earnings released: EPS: US$0.001 (vs US$0.069 in FY 2021) Mar 16
Independent Director exercised options and sold US$101k worth of stock Dec 07
Independent Director exercised options and sold US$114k worth of stock Nov 16
Independent Director exercised options and sold US$114k worth of stock Nov 11
Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Nov 09
InfuSystem Holdings, Inc. Revises Earnings Guidance for the Year 2022 Nov 09
InfuSystem Holdings, Inc. to Report Q3, 2022 Results on Nov 08, 2022 Nov 03
InfuSystem Holdings, Inc. Announces the Appointment of R. Rimmy Malhotra to Board of Directors, Effective September 20, 2022 Sep 24
Independent Director exercised options and sold US$70k worth of stock Sep 13
Executive VP & Chief Commercial Officer exercised options and sold US$56k worth of stock Sep 07
Second quarter 2022 earnings: EPS and revenues miss analyst expectations Aug 05
InfuSystem Holdings Inc. Revises Earnings Guidance for the Year 2022 Aug 05
InfuSystem Holdings, Inc. to Report Q2, 2022 Results on Aug 04, 2022 Jul 30 InfuSystem Holdings, Inc.(NYSEAM:INFU) dropped from Russell 2000 Dynamic Index
Independent Director exercised options and sold US$206k worth of stock Jun 22
Executive VP & Chief Commercial Officer exercised options and sold US$119k worth of stock Jun 11
Independent Director exercised options and sold US$66k worth of stock May 19
InfuSystem Holdings Inc. Approves Appointment of Ralph Boyd to the Company's Board May 19
Consensus EPS estimates fall by 38% May 12
First quarter 2022 earnings: EPS and revenues exceed analyst expectations May 06
InfuSystem Holdings Inc. Provides Earnings Guidance for the Year 2022 May 06
Price target decreased to US$21.67 Apr 27
InfuSystem Holdings Inc., Annual General Meeting, May 17, 2022 Apr 05
Director exercised options and sold US$175k worth of stock Mar 22
Full year 2021 earnings: EPS and revenues miss analyst expectations Mar 17
Consensus EPS estimates fall by 49% Feb 17
Independent Director recently bought US$107k worth of stock Feb 16
Full year 2021 earnings: EPS and revenues miss analyst expectations Feb 12
Investor sentiment deteriorated over the past week Feb 11
InfuSystem Holdings Inc. to Report Q4, 2021 Results on Feb 10, 2022 Feb 10
CEO & Director notifies of intention to sell stock Jan 28
Insider exercised options and sold US$101k worth of stock Dec 01
Third quarter 2021 earnings released: US$0.022 loss per share (vs US$0.15 profit in 3Q 2020) Nov 17
Independent Director exercised options to buy US$399k worth of stock. Nov 14
Investor sentiment improved over the past week Oct 30
Consensus EPS estimates fall to US$0.19 Aug 19
Second quarter 2021 earnings released: EPS US$0.04 (vs US$0.21 in 2Q 2020) Aug 13
InfuSystem Holdings Inc. Revises Earnings Guidance for the Full Year 2021 Aug 13
Investor sentiment deteriorated over the past week Aug 12
Investor sentiment improved over the past week Jul 02
InfuSystem Holdings Inc. (NYSEAM:INFU) announces an Equity Buyback for $20 million worth of its shares. Jul 01
Independent Chairman of the Board exercised options to buy US$421k worth of stock. Jun 30
Infusystem Holdings Inc. Reaffirms Earnings Guidance for Full Year 2021 May 07
First quarter 2021 earnings released: EPS US$0.033 (vs US$0.021 loss in 1Q 2020) May 06
CEO & Director exercised options and sold US$576k worth of stock Apr 19
Independent Director recently bought US$61k worth of stock Mar 30 Shareholder Returns INFU US Healthcare US Market 7D -6.7% -4.1% -2.4% 1Y -22.3% -10.2% 23.3%
See full shareholder returns
Return vs Market: INFU underperformed the US Market which returned 22.1% over the past year.
Price Volatility Is INFU's price volatile compared to industry and market? INFU volatility INFU Average Weekly Movement 9.4% Healthcare Industry Average Movement 7.6% Market Average Movement 6.3% 10% most volatile stocks in US Market 16.8% 10% least volatile stocks in US Market 3.1%
Stable Share Price: INFU has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: INFU's weekly volatility (9%) has been stable over the past year.
About the Company InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
Show more InfuSystem Holdings, Inc. Fundamentals Summary How do InfuSystem Holdings's earnings and revenue compare to its market cap? INFU fundamental statistics Market cap US$169.26m Earnings (TTM ) US$1.48m Revenue (TTM ) US$132.78m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) INFU income statement (TTM ) Revenue US$132.78m Cost of Revenue US$63.89m Gross Profit US$68.90m Other Expenses US$67.41m Earnings US$1.48m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 0.07 Gross Margin 51.89% Net Profit Margin 1.12% Debt/Equity Ratio 50.4%
How did INFU perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/20 11:02 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources InfuSystem Holdings, Inc. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Kyle Bauser B. Riley Securities, Inc. Matthew Hewitt Craig-Hallum Capital Group LLC Alexander Nowak Craig-Hallum Capital Group LLC
Show 5 more analysts 
